Scientific and patient care evidence to change susceptibility breakpoints for first-line anti-tuberculosis drugs
Int J Tuberc Lung Dis
.
2012 May;16(5):706-7.
doi: 10.5588/ijtld.11.0850.
Authors
Jotam G Pasipanodya
,
Shashikant Srivastava
,
Tawanda Gumbo
PMID:
22507940
DOI:
10.5588/ijtld.11.0850
No abstract available
Publication types
Letter
Comment
MeSH terms
Bacterial Proteins / genetics*
DNA, Bacterial / genetics*
Humans
Mutation*
Mycobacterium tuberculosis / genetics*
Tuberculosis, Multidrug-Resistant / genetics*
Substances
Bacterial Proteins
DNA, Bacterial